MDS-435: Effect of Ianalumab Plus Eltrombopag on Patient-Reported Outcomes in Primary Immune Thrombocytopenia: Results From the VAYHIT2 Phase 3 Trial
Bildiriler > Özet Bildiri
Yazarlar: Nichola Cooper, Adam Cuker, Tuphan Dolai, Waleed Ghanima, David Gómez Almaguer, Arpad Illes, Marc Michel, Luminita Ocroteala, Sue Pavord, Veronica Privitera, Fahri Sahin, Thomas Stauch, Marek Trneny, Raymond Wong, Tie-Nan Zhu, Martina Crysandt, Rahim Lalji, Marine Weill, Patrick Urban, Justyna Fronczek, Matthew Foster, Hanny Al-Samkari
Clinical Lymphoma Myeloma and Leukemia, , , Uluslararası, Özet Bildiri, Wos, cilt 26, ss S708-S708